New support team aims to bridge the gap from hospital to mental health care for psychosis
NCT ID NCT07713849
First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time
Summary
This study tests a Transition Care Team (TCT) designed to help people with first episode psychosis successfully move from hospital to outpatient mental health services. The TCT provides short-term support including therapy, case management, and coordination with community programs. The main goal is to see if this approach increases the number of patients who start outpatient treatment within six weeks of leaving the hospital, compared to usual care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Transition Care Team (TCT), a multidisciplinary support model including psychoeducation, case management, peer support, and care coordination
- What this could lead to
- If successful, this approach could help more people with first episode psychosis stay connected to care after hospitalization, potentially improving their long-term outcomes.
- What could go wrong
- This is a small, early-stage study with 75 participants, so results may not apply broadly. The intervention may not significantly improve engagement compared to standard discharge referrals.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 75 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2026
- Expected to finish
-
May 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Subjects will be recruited from those admitted to the psychiatry units in the Wyman Gordon building at University of Chicago Ingalls Memorial hospital.
- Ages
-
18 to 40 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder with psychotic features, major depressive disorder with psychotic features, schizophreniform disorder, or psychosis NOS * The diagnosis of one of the psychotic disorders has a duration of less than two years. * Able to read, speak, and understand English, which will be assessed through observation. * Able and willing to provide written informed consent or assent, in cases where caregivers are considered legal guardians. Dr. Shima, co-I of the study, is a forensic psychiatrist, and particularly adept at judging such ability. Drs. Erickson and Keedy have conducted studies in individuals with psychotic disorders, including FEP and in the context of clinical trials, for years, and are similarly competent to judge whether individuals can provide informed consent. Finally, we will also use an Evaluation to Sign Consent form that documents subjects' verbalized understanding of key aspects of the study. * have an estimated IQ of \> 65, assessed by the Wechsler Test of Adult Reading * Eligible caregivers/proxy informants must be identified by the participant or clinical team as being involved in the participant's discharge planning or follow-up care, be able to provide informed verbal consent, and be able to speak and read English sufficiently to complete study questionnaires. Caregivers may include family members, close supports, or legally authorized representatives. Exclusion Criteria: * Individuals with substance-induced psychosis or psychosis due to a medical condition will not be included in the study. We will use the Structured Clinical Interview for DSM-5 as well as medical records, and if the subject gives permission, caregiver information in this process * Individuals who do not meet criteria for a first episode of psychosis
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bipolar disorder with psychotic features are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
University of Chicago Ingalls Memorial Hospital
RECRUITINGHarvey, Illinois, 60426, United States
-
University of Chicago Medical Center, Biological Science Division
ACTIVE_NOT_RECRUITINGChicago, Illinois, 60637, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can talk therapy and social coaching ease early psychosis?
- Mood-Boosting activities put to the test in schizophrenia
- Can adding lurasidone to antidepressants lift depression that Won't budge?
- Can a dissolving film tame agitation in schizophrenia?
- Brain training and exercise from home: a new hope for early schizophrenia?
- Blood inflammation may hold clues to psychiatric diagnosis